ClearPoint Neuro Inc.
Long

Clearpoint Neuro

119
Clearpoint Neuro, functional neurosurgery platform with rapid growth within the biologics & gen therapy segment. Breakout out of a multi-year trend with re-test of previous resistance level on low volume. Expecting this to pop over the the next few months with the continued net growth and EPS.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.